Curaleaf Formally Launches $4-Per-Share Takeover Bid for Aurora Cannabis

Curaleaf Holdings has launched a $4-per-share takeover bid for Aurora Cannabis, offering 0.3463 subordinate voting shares and $0.75 cash per share. The bid, open until December 1, represents a 45% premium to Aurora's 30-day average price. Curaleaf expects $40M in annual cost savings and a combined revenue of $1.5B. Aurora's special committee has not yet recommended the offer.

Original reporting
Published Aug 18, 2026, 1:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 9:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Curaleaf Formally Launches $4-Per-Share Takeover Bid for Aurora Cannabis — source image
Decision brief

The 30-second read

High
01

Why it matters

The bid aims to create a $3 billion pro‑forma company with $1.5 billion revenue and $350 million EBITDA.

02

Market read

The announcement introduces a significant M&A event in the cannabis industry, affecting both U.S. and Canadian markets.

03

What to watch

Potential integration costs and cultural differences may erode projected synergies.

Relevance 9/10Novelty 9/10Timing: announcement today, offer open until Dec 1

Background

Curaleaf and Aurora have been in talks; previous attempts failed, prompting a formal bid.

Market effects

Consolidation in the cannabis sector may pressure other fragmented players.

U.S. and Canadian cannabis markets could see valuation adjustments.

Creates a larger, diversified global cannabis platform with cross‑border reach.

Counterpoint

Deal could face regulatory hurdles and financing challenges, risking a collapse.

Key entities

  • Boris Jordan

    Chairman and CEO of Curaleaf, leading the acquisition effort.

  • Aurora Special Committee

    Body reviewing the takeover proposal on behalf of Aurora shareholders.

Related articles

$ACBMed

AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.

Aurora Cannabis (TSX: ACB, NASDAQ: ACB) has urged shareholders to take no action regarding Curaleaf's (TSX: CURA, OTCQX: CURLF) unsolicited takeover bid of $4.00 per share, consisting of 0.3463 Curaleaf shares plus $0.75 in cash. Aurora's CEO, Miguel Martin, stated that Curaleaf's offer is designed to pressure shareholders into a short-term decision. Aurora has engaged with Curaleaf since June 2026 and plans to provide a comprehensive response to shareholders in due course.

HighAI 9/10

Curaleaf Advances Aurora Acquisition Strategy with Direct Shareholder Offer

Curaleaf Holdings proposed a $4.00 per share offer to acquire Aurora Cannabis, citing Aurora's underperformance and regulatory challenges. The offer includes a 45% premium and aims to create a larger, diversified cannabis platform. Aurora's board has not yet responded positively, and both companies have publicly discussed the proposal. Curaleaf's offer is structured as 0.3463 subordinate voting shares and $0.75 in cash per Aurora share, representing a 110% premium excluding Aurora's cash and cas

$ACBHighAI 9/10

Curaleaf’s Hostile Bid For Aurora Is Official

Curaleaf has made a public hostile bid for Aurora, offering $4 per share, a 45% premium on Aurora's 30-day average. Curaleaf aims to create a $3B combined company with cost synergies and access to EU medical cannabis markets. Aurora's board is reviewing the deal. Shares of both companies moved on the news.

$CURLFHighAI 9/10

Curaleaf launches US$260 million takeover bid for Canadian producer Aurora Cannabis

Curaleaf Holdings launched a takeover bid for Aurora Cannabis valuing it at about US$260 million, a week after its initial proposal, according to Curaleaf and Reuters. Aurora shareholders would receive 0.3463 Curaleaf shares and $0.75 cash per share, about $4 total, with a cap tied to Curaleaf’s stock. The offer runs until Dec. 1 pending approvals and majority support.

$ACBHighAI 9/10

Curaleaf launches $260-million takeover bid for Aurora Cannabis

Curaleaf Holdings launched a takeover bid for Aurora Cannabis valuing it at about US$260 million. Aurora shareholders would receive 0.3463 Curaleaf shares plus $0.75 cash per share, totaling $4 per share, with a cap at $5 if Curaleaf stock rises. The offer runs until Dec. 1, pending approvals and majority support. Aurora shares rose 3% early.